ReviewFrontiers in neuroscience2020

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Mara Dierssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.